Penny Stock News Algernon Announces Enrollment of 50th Patient in Multinational 2b/3 Human Study of Ifenprodil for Treatment of COVID-19 VANCOUVER, British Columbia, Sept. 02, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc.… September 2, 20208.1K views4 minute read
Penny Stock News Algernon CEO Presents Corporate Update Featured on BioPub Webcast Hosted by Dr. KSS MD PhD VANCOUVER, British Columbia, Aug. 17, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc.… August 17, 20209.0K views4 minute read
Penny Stock News Algernon Announces Enrollment of First U.S. Patient in Multinational Phase 2b/3 Human Study of Ifenprodil for Treatment of COVID-19 VANCOUVER, British Columbia, Aug. 13, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc.… August 13, 20207.0K views4 minute read
Penny Stock News A Pill That May Lessen COVID-Related Lung Damage. Miami Will Be First In U.S. To Test It A Miami hospital will be the first in the country to test… August 10, 202012.5K views3 minute read
Penny Stock News Algernon Announces First Patient Dosed in Phase 2 IPF and Chronic Cough Human Trial of Ifenprodil VANCOUVER, British Columbia, Aug. 05, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc.… August 5, 20208.9K views4 minute read
Penny Stock News Algernon Highlights UT Dallas Research Study Identifying Ifenprodil as a Possible COVID-19 Treatment VANCOUVER, British Columbia, July 21, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc.… July 21, 20205.6K views5 minute read
Penny Stock News Algernon Announces First U.S. Clinical Trial Site in Florida for Phase 2b/3 Human Study of Ifenprodil for COVID-19 VANCOUVER, British Columbia, July 16, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc.… July 16, 20205.6K views5 minute read
Penny Stock News Algernon Begins Screening Patients for Phase 2 Ifenprodil IPF and Chronic Cough Human Study in Australia VANCOUVER, British Columbia, July 07, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc.… July 7, 20205.5K views4 minute read
Penny Stock News Algernon Receives Ethics Approval for U.S. Sites for 2b/3 Human Study of Ifenprodil for COVID-19 VANCOUVER, British Columbia, June 25, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc.… June 25, 20204.9K views8 minute read
Biotech Stocks Penny Stock News Algernon Receives U.S. FDA Clearance for Multinational Phase 2b/3 Human Study to Evaluate Ifenprodil as a Potential Therapeutic for COVID-19 VANCOUVER, British Columbia, June 04, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc.… June 4, 20209.7K views4 minute read
